MOTS-C

Mitochondrial Open Reading Frame of the 12S rRNA-c

MOTS-C is a 16-amino acid mitochondrial-derived peptide (MDP) encoded by mitochondrial DNA. It plays a crucial role in regulating metabolic homeostasis, glucose metabolism, and insulin sensitivity. MOTS-C has shown promising therapeutic potential in aging, diabetes management, cardiovascular health, and physical performance enhancement. Currently in research phase with no clinical approval.

Complete Dosing Guide

Quick Reference

Research

Typical Dose

Variable

Frequency

Approximately

Half-Life

SubQ

Route

Administration Method

Subcutaneous injection, research protocols vary

Step-by-Step Dosing Protocol

Initial

Research protocols: 5-15 mg/kg subcutaneously (animal studies)

Getting started

Follow gradual escalation approach

Maintenance

Optimized dose

Sustained benefits

Continue at effective dose

Cycling

Break period

Recovery

Take breaks to maintain effectiveness

Dosage Calculator

Dose Calculator

Peptide Amount (mg only)

Solution Volume

Desired Dose

Peptide amount must be greater than 0

Medical Disclaimer

MOTS-C is an experimental peptide not approved by the FDA for therapeutic use. It is banned by WADA for athletic competition. All information is for educational purposes only and should not constitute medical advice. Consult healthcare professionals before considering any peptide therapy. Long-term safety and efficacy in humans remain unknown.

Peptide Database